All Blood Diseases reports APO Research, Inc.
All APO Research, Inc. reports Life SciencesPharmaceuticalsDiseases & Conditions Blood Diseases

Publisher: APO Research, Inc.
Category: Blood Diseases

Blood Diseases market research reports by APO Research, Inc.

(6 reports matching your criteria)

    • Global Hemophilia Gene Therapy Market Analysis and Forecast 2024-2030

      Apr 24, 2024  |  Published by: APO Research, Inc.  |  USD 4,950

      Global Hemophilia Gene Therapy Market Analysis and Forecast 2024-2030 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutat ... Read More

    • Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

      Apr 23, 2024  |  Published by: APO Research, Inc.  |  USD 3,950

      Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There ... Read More

    • Hemophilia Gene Therapy Industry Research Report 2024

      Apr 23, 2024  |  Published by: APO Research, Inc.  |  USD 2,950

      Hemophilia Gene Therapy Industry Research Report 2024 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes th ... Read More

    • Global Hemophilia Gene Therapy Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

      Apr 23, 2024  |  Published by: APO Research, Inc.  |  USD 4,250

      Global Hemophilia Gene Therapy Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two type ... Read More

    • Global Hemophilia Gene Therapy Market Size, Manufacturers, Opportunities and Forecast to 2030

      Apr 23, 2024  |  Published by: APO Research, Inc.  |  USD 3,450

      Global Hemophilia Gene Therapy Market Size, Manufacturers, Opportunities and Forecast to 2030 Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of he ... Read More

    • Sickle Cell Anemia Therapeutics Industry Research Report 2024

      Feb 25, 2024  |  Published by: APO Research, Inc.  |  USD 2,950

      Sickle Cell Anemia Therapeutics Industry Research Report 2024 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of ... Read More

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help

Join Alert Me Now!

Receive bi-weekly email alerts on new research

Sign Up

Find out more on our blog
Cookie Settings